PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,730,000 | +96.4% | 17,500 | -41.7% | 1.13% | +248.9% |
| Q1 2016 | $881,000 | -55.1% | 30,000 | +20.0% | 0.32% | -49.9% |
| Q4 2015 | $1,960,000 | -66.8% | 25,000 | 0.0% | 0.64% | -74.0% |
| Q1 2015 | $5,903,000 | +211.8% | 25,000 | +150.0% | 2.48% | +171.4% |
| Q4 2014 | $1,893,000 | -20.7% | 10,000 | 0.0% | 0.92% | -28.2% |
| Q3 2014 | $2,386,000 | +31.5% | 10,000 | -63.6% | 1.27% | +50.4% |
| Q2 2014 | $1,815,000 | -50.2% | 27,500 | -21.4% | 0.85% | -49.7% |
| Q1 2014 | $3,645,000 | +40.8% | 35,000 | +40.0% | 1.68% | +14.2% |
| Q4 2013 | $2,588,000 | – | 25,000 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |